By that time the Dana Farber trial will be stopped for Kevetrin efficacy, FDA will have bypassed breakthrough designation and Kevetrin should be in production and available at any local CVS at the register next to the 5 hour energy drinks. Prurisol will have a licensing agreement with PFE for $20 billion and Celgene will have purchased the autism compound and Kard Scientific for $50 billion which equates too $6,486 per share by Labor Day . . . oh wait a minute . . . wrong board . . . this isn't iHub?!!!